Fredun Pharmaceuticals Limited share price

Key numbers

Market cap

₹ 2,293 Cr

Current price

₹ 1,356.60

52-week high / low

₹ 1,536 / 1,195

Stock P/E

59.0

Book value

₹ 169.4

Dividend yield

0.05%

ROCE

20.3%

ROE

15.4%

Debt to equity

0.86

Sales growth (3 yrs)

32.2%

Profit growth (3 yrs)

44.5%

1-year return

-

About Fredun Pharmaceuticals Limited

Fredun Pharmaceuticals Limited manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, animal healthcare products, cosmeceuticals, mobility and rehabilitation products, and other healthcare products in India, Africa, Southeast Asia, Commonwealth of Independent States countries, MENA region, and Latin America. The company offers allopathic formulations, including analgesics/NSAID, antacid/antiulcer, anthelmintic, antibacterial, anti-diabetic, anti-inflammatory, anti-malarial, anti-obesity, antacid, anthelmintic, anticoagulants, anticonvulsants, antidiarrhoeal, antidepressant, antifungal, antihistamines/antiallergic, antihypertensives, antiviral, bone modulating drugs, bronchodilators and anti-asthma drugs, calcium tablets, cardiovascular, diuretic, impotence drugs, laxative, and appetite stimulant with multivitamins. It also provides surgical products, such as IV fluids and cannulas, disposable syringes, infusion sets, surgical gloves and cottons, and personal healthcare products; APIs; direct compressible granules; pellets; animal healthcare products; aqua products; and niche products. Additionally, the company offers therapeutic products…

Quarterly results

Consolidated figures in ₹ crores

Peers in Drug Manufacturers - Specialty & Generic

• Sun Pharmaceutical Industries Limited
• Divi's Laboratories Limited
• Torrent Pharmaceuticals Limited
• Zydus Lifesciences Limited
• Cipla Limited
• Laurus Labs Limited
• Mankind Pharma Limited
• Dr. Reddy's Laboratories Limited
• Aurobindo Pharma Limited
• Lupin Limited